Can Insilico's Drug Help Turn Back the Biological Clock? | The China Show | 9/8/2026

Insilico Medicine announced development of a drug candidate targeting aging processes. The company, based in Hong Kong and founded by AI researcher Alexei Fedorov, uses artificial intelligence to identify molecular targets associated with aging. Bloomberg's "The China Show" featured discussion of the drug development on September 8, 2026. No clinical trial results or regulatory approval status was specified in available reports.

Next story